Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Apr 12, 2021Discovery and characterization of a novel anti-human CXCR5 antibody for the treatment of B cell lymphomasApr 6, 2021HiFiBiO Therapeutics to Present Progress on Four Novel Immunotherapy Programs at AACR 2021Mar 19, 2021HiFiBiO and Gustave Roussy Researchers Demonstrate the Contribution of Galectin-9 (Gal-9) in Tumor Immune EscapeLioness Magazine Interview | Interview | Mar 11, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Lioness MagazinePharmaBoardRoom Article | Article | Mar 8, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis Podcast< 1 … 7 8 9 10 11 … 17 >
